Ultragenyx Pharmaceutical Inc.’s recent filing unveils that its President & CEO KAKKIS EMIL D unloaded Company’s shares for reported $1.12 million on Sep 03 ’24. In the deal valued at $55.85 per share,20,000 shares were sold. As a result of this transaction, KAKKIS EMIL D now holds 2,223,985 shares worth roughly $119.63 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Huizenga Theodore Alan sold 91 shares, generating $5,113 in total proceeds. Upon selling the shares at $56.19, the SVP, Chief Accounting Officer now owns 41,551 shares.
Before that, KAKKIS EMIL D bought 20,000 shares. Ultragenyx Pharmaceutical Inc. shares valued at $1,117,096 were divested by the Officer at a price of $55.85 per share.
Goldman upgraded its Ultragenyx Pharmaceutical Inc. [RARE] rating to a Buy from a a Neutral in a research note published on June 06, 2024; the price target was increased to $67 from $56. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in late April with a ‘”an Outperform”‘ rating. Wells Fargo began covering RARE with “an Overweight” recommendation on December 08, 2023.
Price Performance Review of RARE
On Friday, Ultragenyx Pharmaceutical Inc. [NASDAQ:RARE] saw its stock jump 0.24% to $53.79. Over the last five days, the stock has lost -1.18%. Ultragenyx Pharmaceutical Inc. shares have risen nearly 12.48% since the year began. Nevertheless, the stocks have risen 57.10% over the past one year. While a 52-week high of $60.37 was reached on 09/16/24, a 52-week low of $31.52 was recorded on 06/18/24. SMA at 50 days reached $54.05, while 200 days put it at $47.13.
Levels Of Support And Resistance For RARE Stock
The 24-hour chart illustrates a support level at 53.17, which if violated will result in even more drops to 52.54. On the upside, there is a resistance level at 54.46. A further resistance level may holdings at 55.12. The Relative Strength Index (RSI) on the 14-day chart is 42.08, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.11, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.33%. Stochastics %K at 12.15% indicates the stock is a buying.
How much short interest is there in Ultragenyx Pharmaceutical Inc.?
A steep rise in short interest was recorded in Ultragenyx Pharmaceutical Inc. stocks on 2024-09-13, dropping by -0.23 million shares to a total of 3.61 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 3.85 million shares. There was a decline of -6.44%, which implies that there is a negative sentiment for the stock.
